Literature DB >> 25155035

Age-related prevalence of diabetes mellitus, cardiovascular disease and anticoagulation therapy use in a urolithiasis population and their effect on outcomes: the Clinical Research Office of the Endourological Society Ureteroscopy Global Study.

F Pedro J Daels1, Andrius Gaizauskas, Jorge Rioja, Anil K Varshney, Erkan Erkan, Yasar Ozgok, Michael Melekos, Jean J M C H de la Rosette.   

Abstract

PURPOSE: This study examined the prevalence of risk factors for urological stone surgery and their possible influence on outcome and complications following ureteroscopy (URS).
METHODS: The Clinical Research Office of the Endourological Society Ureteroscopy Global Study collected prospective data on consecutive patients with urinary stones treated with URS at centers around the world for 1 year. The prevalence of common comorbidities and anticoagulation therapy and their relationship with complications and age were examined.
RESULTS: Of 11,719 patients, 2,989 patients (25.8%) had cardiovascular disease, including 22.6% with hypertension, and 1,266 patients (10.9%) had diabetes mellitus. Approximately six percent of patients were receiving oral anticoagulation therapy, including aspirin (3.7%) and clopidogrel (0.8%). The prevalence of hypertension and diabetes mellitus and the proportion of patients receiving anticoagulant medication and/or antidiabetes treatment increased with age. Elderly were more likely to develop a postoperative complication when they had diabetes, a cardiovascular disease or received anticoagulation therapy. Post-operative bleeding was higher in patients receiving anticoagulants than those not receiving them (1.1 vs. 0.4%; p < 0.01). Patients with risk factors for stone formation had more complications than those without (4.9 vs. 3.0%, p < 0.001).
CONCLUSIONS: This is the first study confirming in a global population that URS can effectively and safely be performed in a population with high comorbidity. The risk of a complication was highest among elderly patients presenting with comorbidities.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25155035     DOI: 10.1007/s00345-014-1382-6

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  19 in total

1.  Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000.

Authors:  A Hesse; E Brändle; D Wilbert; K-U Köhrmann; P Alken
Journal:  Eur Urol       Date:  2003-12       Impact factor: 20.096

Review 2.  Epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  J Am Soc Nephrol       Date:  1998-12       Impact factor: 10.121

3.  Flexible regression models with cubic splines.

Authors:  S Durrleman; R Simon
Journal:  Stat Med       Date:  1989-05       Impact factor: 2.373

4.  Urologic diseases in America project: urolithiasis.

Authors:  Margaret S Pearle; Elizabeth A Calhoun; Gary C Curhan
Journal:  J Urol       Date:  2005-03       Impact factor: 7.450

5.  Global burden of hypertension: analysis of worldwide data.

Authors:  Patricia M Kearney; Megan Whelton; Kristi Reynolds; Paul Muntner; Paul K Whelton; Jiang He
Journal:  Lancet       Date:  2005 Jan 15-21       Impact factor: 79.321

6.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

Review 7.  Current status of ureteroscopic treatment for urolithiasis.

Authors:  Andreas A Skolarikos; Athanasios G Papatsoris; Iraklis C Mitsogiannis; Lefteris Chatzidarellis; Christos Liakouras; Charalambos Deliveliotis
Journal:  Int J Urol       Date:  2009-08-06       Impact factor: 3.369

8.  The clinical research office of the endourological society ureteroscopy global study: indications, complications, and outcomes in 11,885 patients.

Authors:  Jean de la Rosette; John Denstedt; Petrisor Geavlete; Francis Keeley; Tadashi Matsuda; Margaret Pearle; Glenn Preminger; Olivier Traxer
Journal:  J Endourol       Date:  2013-12-17       Impact factor: 2.942

9.  Prevalence and epidemiological characteristics of urolithiasis in Japan: national trends between 1965 and 2005.

Authors:  Takahiro Yasui; Masanori Iguchi; Sadao Suzuki; Kenjiro Kohri
Journal:  Urology       Date:  2008-02       Impact factor: 2.649

Review 10.  New insights into the pathogenesis of renal calculi.

Authors:  Herman Singh Bagga; Thomas Chi; Joe Miller; Marshall L Stoller
Journal:  Urol Clin North Am       Date:  2012-10-23       Impact factor: 2.241

View more
  4 in total

1.  Identification of factors associated with postoperative febrile urinary tract infection after ureteroscopy for urinary stones.

Authors:  Koji Mitsuzuka; Osamu Nakano; Norio Takahashi; Makoto Satoh
Journal:  Urolithiasis       Date:  2015-09-01       Impact factor: 3.436

2.  Retrograde intrarenal surgery and percutaneous nephrolithotomy for the treatment of stones in horseshoe kidney; what are the advantages and disadvantages compared to each other?

Authors:  Ibrahim Kartal; Mehmet Çağlar Çakıcı; Volkan Selmi; Sercan Sarı; Harun Özdemir; Hamit Ersoy
Journal:  Cent European J Urol       Date:  2019-05-31

3.  Ureteroscopy: a population based study of clinical complications and possible risk factors for stone surgery.

Authors:  Magnus Wagenius; Mattias Rydberg; Marcin Popiolek; Andreas Forsvall; Johan Stranne; Adam Linder
Journal:  Cent European J Urol       Date:  2019-09-02

Review 4.  Recent evidence for anatomic endoscopic enucleation of the prostate (AEEP) in patients with benign prostatic obstruction on antiplatelet or anticoagulant therapy.

Authors:  C Netsch; T R W Herrmann; G Bozzini; L Berti; A J Gross; B Becker
Journal:  World J Urol       Date:  2021-03-15       Impact factor: 4.226

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.